Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study
- DOI
- 10.1016/j.healun.2024.11.026
- Published
- 2025-06
- Container
- The Journal of Heart and Lung Transplantation
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.healun.2024.11.026,
title = {Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study},
author = {Emily A. Blumberg and Oliver Witzke and Mark Harber and Michael G. Ison and Faouzi Saliba and Nassim Kamar and Aimee K. Sundberg and Joan Gu and Deepali Kumar and Ricardo M. La Hoz},
year = {2025},
journal = {The Journal of Heart and Lung Transplantation},
doi = {10.1016/j.healun.2024.11.026},
url = {https://doi.org/10.1016/j.healun.2024.11.026}
}RIS
TY - JOUR TI - Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study AU - Emily A. Blumberg AU - Oliver Witzke AU - Mark Harber AU - Michael G. Ison AU - Faouzi Saliba AU - Nassim Kamar AU - Aimee K. Sundberg AU - Joan Gu AU - Deepali Kumar AU - Ricardo M. La Hoz PY - 2025 JO - The Journal of Heart and Lung Transplantation DO - 10.1016/j.healun.2024.11.026 UR - https://doi.org/10.1016/j.healun.2024.11.026 ER -
APA
Blumberg, E. A., Witzke, O., Harber, M., Ison, M. G., Saliba, F., Kamar, N., Sundberg, A. K., Gu, J., Kumar, D., & Hoz, R. M. L. (2025). Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study. The Journal of Heart and Lung Transplantation. https://doi.org/10.1016/j.healun.2024.11.026
Source records
- crossref · retrieved 2026-09-27T02:34:54.399Z